EUVIMEDEUVIMED entdecken
Crossref

Selective Synergy of the Combination of Recombinant Methioninase With Cisplatinum and Ivermectin Which Eradicates Lung-Cancer Cells but Has No Synergy and Limited Effect on Normal Fibroblasts

Yohei Asano, Qinghong Han, Shukuan Li, Kohei Mizuta, Byung Mo Kang, Jin Soo Kim, Yuta Miyashi, Norio Yamamoto, Katsuhiro Hayashi, Hiroaki Kimura, Shinji Miwa, Kentaro Igarashi und 5 weitere

Anticancer Research · 2025

DOI: 10.21873/anticanres.17875 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2025. Verfasst von Yohei Asano und 16 weiteren Autor:innen. Beteiligte Einrichtung: AntiCancer Inc., San Diego, CA, U.S.A. Hauptthemen laut MEDLINE: Carbon-Sulfur Lyases, Cisplatin, Ivermectin, Fibroblasts.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carbon-Sulfur LyasesCisplatinIvermectinFibroblastsLung NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsHumansDrug SynergismRecombinant ProteinsA549 CellsCell SurvivalCell Line, TumorAntineoplastic Agents

Stichwörter der Autor:innen

Hoffman effectRecombinant methioninase (rMETase)cisplatinumcombination treatmentivermectinlung cancer cellsmethionine addictionnormal fibroblastsselective synergy

Substanzen

Carbon-Sulfur LyasesCisplatinL-methionine gamma-lyaseIvermectinRecombinant ProteinsAntineoplastic Agents

Autor:innen und Institutionen

  • AntiCancer Inc., San Diego, CA, U.S.A.
  • Department of Surgery, University of California, San Diego, CA, U.S.A.
  • Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.
  • AntiCancer Inc., San Diego, CA, U.S.A.; all@anticancer.com.

Zitieren

APA

Asano, Y., Han, Q., Li, S., Mizuta, K., Kang, B. M., Kim, J. S., Miyashi, Y., Yamamoto, N., Hayashi, K., Kimura, H., Miwa, S., Igarashi, K., Higuchi, T., Morinaga, S., Tsuchiya, H., Demura, S., & Hoffman, R. M. (2025). Selective Synergy of the Combination of Recombinant Methioninase With Cisplatinum and Ivermectin Which Eradicates Lung-Cancer Cells but Has No Synergy and Limited Effect on Normal Fibroblasts. Anticancer Research. https://doi.org/10.21873/anticanres.17875

Vancouver

Asano Y, Han Q, Li S, Mizuta K, Kang BM, Kim JS, et al. Selective Synergy of the Combination of Recombinant Methioninase With Cisplatinum and Ivermectin Which Eradicates Lung-Cancer Cells but Has No Synergy and Limited Effect on Normal Fibroblasts. Anticancer Research. 2025. doi:10.21873/anticanres.17875

BibTeX
@article{Asano2025,
  author = {Asano, Yohei and Han, Qinghong and Li, Shukuan and Mizuta, Kohei and Kang, Byung Mo and Kim, Jin Soo and Miyashi, Yuta and Yamamoto, Norio and Hayashi, Katsuhiro and Kimura, Hiroaki and Miwa, Shinji and Igarashi, Kentaro and Higuchi, Takashi and Morinaga, Sei and Tsuchiya, Hiroyuki and Demura, Satoru and Hoffman, Robert M},
  title = {Selective Synergy of the Combination of Recombinant Methioninase With Cisplatinum and Ivermectin Which Eradicates Lung-Cancer Cells but Has No Synergy and Limited Effect on Normal Fibroblasts},
  journal = {Anticancer Research},
  year = {2025},
  doi = {10.21873/anticanres.17875}
}
Kostenlos starten →